Atlas Trials

Arcellx, Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Arcellx, Inc.

RecordFirmDate
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases (NCT06626919)Arcellx, Inc.2025-04-30
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS (NCT05457010)Arcellx, Inc.2022-11-28

Track Arcellx, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.